Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP102771.RAUNPK3-eSIXbAUn3aod3KNq3A93_y930Ddpm3aOn3cZU130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP102771.RAUNPK3-eSIXbAUn3aod3KNq3A93_y930Ddpm3aOn3cZU130_provenance.
• assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP147387.RAVK02YKz_nRcNN2OaOsiFWFlCbMN80dLNFStIxmZpQi0130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147387.RAVK02YKz_nRcNN2OaOsiFWFlCbMN80dLNFStIxmZpQi0130_provenance.
• assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP88832.RAmzp8W-yWNqIfhqo9VR_lsn-a4isQkgIJr_37p8gjSTQ130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88832.RAmzp8W-yWNqIfhqo9VR_lsn-a4isQkgIJr_37p8gjSTQ130_provenance.
• NP124711.RAnJWeZXc6Zy7L0cGny1HI_ocLiTbLJJHhwvAWp-qpE44130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP124711.RAnJWeZXc6Zy7L0cGny1HI_ocLiTbLJJHhwvAWp-qpE44130_provenance.
• NP147390.RAiGUAIvfUpCKI0E2xgXV6k0XrcGSCSNWXedX90Teh660130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147390.RAiGUAIvfUpCKI0E2xgXV6k0XrcGSCSNWXedX90Teh660130_provenance.
• NP89802.RA0c-YpZkllbzWtTpST0OaI9JSVpLkkxnyVhicz1X38AI130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89802.RA0c-YpZkllbzWtTpST0OaI9JSVpLkkxnyVhicz1X38AI130_provenance.
• NP89804.RAzvQ1dLOH1wwKe9N-1Qr3N25E-cnr8HGurAaQDnzB8rk130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP89804.RAzvQ1dLOH1wwKe9N-1Qr3N25E-cnr8HGurAaQDnzB8rk130_provenance.
• NP102769.RALrHQsshiMftoUaAZqcfm3eXrd7pAAHFpFG7ODedTdZk130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP102769.RALrHQsshiMftoUaAZqcfm3eXrd7pAAHFpFG7ODedTdZk130_provenance.
• NP464952.RAI1MBD1Ch1f3guNGyBSGS4bbchg_eYoTIbqCRspkH4mo130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP464952.RAI1MBD1Ch1f3guNGyBSGS4bbchg_eYoTIbqCRspkH4mo130_provenance.
• NP147392.RANOfvHAJ2P9u_TGuPN_HUr1p9Uhg4wBTfacByUAcphoo130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147392.RANOfvHAJ2P9u_TGuPN_HUr1p9Uhg4wBTfacByUAcphoo130_provenance.
• NP738898.RAzkggmHlmRqsgnBKIONzIkJuWfYLy3IBpI9T7Wvha8UU130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738898.RAzkggmHlmRqsgnBKIONzIkJuWfYLy3IBpI9T7Wvha8UU130_provenance.
• NP738899.RA94NCxFzDCOWPCi3rCYpPXBn7gWoBocLoS2Dg1hhC5rw130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738899.RA94NCxFzDCOWPCi3rCYpPXBn7gWoBocLoS2Dg1hhC5rw130_provenance.
• NP738900.RA_9TSbS5Yql7BOp0jfoinFpaulh_vmordSjec-rcv7Io130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738900.RA_9TSbS5Yql7BOp0jfoinFpaulh_vmordSjec-rcv7Io130_provenance.
• NP147391.RA6Mt_p3tx0vuuSXTyWpdrlZT3668Zt-SUtnq9c1CDX2o130_assertion description "[Our data provide evidence that oncogenic properties of KRAS and BRAF but not NRAS, HRAS, and PIK3CA contribute to the tumorigenesis of periampullary and ampullary tumors; BRAF mutations occur more frequently in periampullary than ampullary neoplasms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP147391.RA6Mt_p3tx0vuuSXTyWpdrlZT3668Zt-SUtnq9c1CDX2o130_provenance.